REGENXBIO Trademark

Trademark Overview

On Wednesday, September 17, 2014, a trademark application was filed for REGENXBIO with the United States Patent and Trademark Office. The USPTO has given the REGENXBIO trademark a serial number of 86397777. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, February 18, 2023. This trademark is owned by REGENXBIO Inc.. The REGENXBIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Custom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, and RNA interference (RNAi); Scientific and medical research and development; genetic engineering services, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors
regenxbio

General Information

Serial Number86397777
Word MarkREGENXBIO
Filing DateWednesday, September 17, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, February 18, 2023
Registration Number5018429
Registration DateTuesday, August 9, 2016
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 15, 2016

Trademark Statements

Description of MarkThe mark consists of a cluster of circles of varying size which create a larger circle. The cluster of circles surround a circle with a triangular shape inside. The wording "REGENXBIO" in stylized form appears to right of the cluster of circles.
Pseudo MarkREGEN X BIO
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesCustom development of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy, development of pharmaceutical preparations for use in gene therapy, and therapeutic compositions that include recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific expression of biologics with therapeutic effect in gene therapy, and RNA interference (RNAi); Scientific and medical research and development; genetic engineering services, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools, including those based on recombinant adeno-associated viral vectors

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 24, 2014
Primary Code042
First Use Anywhere DateMonday, September 1, 2014
First Use In Commerce DateMonday, September 1, 2014

Trademark Owner History

Party NameREGENXBIO Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameREGENXBIO Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Saturday, June 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, June 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, June 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 19, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 18, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, February 18, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 3, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, August 9, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, June 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, August 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, August 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, August 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, August 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, August 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, June 21, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, June 21, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, June 21, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, June 21, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, June 21, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 7, 2018COUNTERCLAIM OPP. NO. 999999
Thursday, January 25, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 25, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 26, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 26, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 9, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, July 6, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 5, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 28, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 8, 2016USE AMENDMENT FILED
Tuesday, June 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 8, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 10, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, February 1, 2016EXPARTE APPEAL TERMINATED
Monday, February 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 29, 2016AMENDMENT FROM APPLICANT ENTERED
Friday, January 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 28, 2016PAPER RECEIVED
Monday, January 25, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 25, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 22, 2016ASSIGNED TO LIE
Monday, January 11, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, January 11, 2016EX PARTE APPEAL-INSTITUTED
Monday, January 11, 2016JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, January 11, 2016EXPARTE APPEAL RECEIVED AT TTAB
Friday, July 10, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 10, 2015FINAL REFUSAL E-MAILED
Friday, July 10, 2015FINAL REFUSAL WRITTEN
Thursday, June 25, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 25, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 25, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 23, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, April 23, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 6, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2015NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2015NON-FINAL ACTION WRITTEN
Tuesday, December 30, 2014ASSIGNED TO EXAMINER
Thursday, September 25, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 24, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 20, 2014NEW APPLICATION ENTERED

Related Keywords

regenxbio research gene development therapy therapeutic recombinant viral services associated adeno